Sales and Marketing

Showing 15 posts of 11528 posts found.

Dompé gives the FDA its first approved neurotrophic keratitis treatment

August 24, 2018 Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma

Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic …

Top Ten most popular articles on Pharmafile.com this week

August 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …

$3 million GSK verdict thrown out of court

August 23, 2018 Sales and Marketing GSK, Litigation, antidepressants, suicide, verdict

A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …

FDA refuses Allergan’s uterine bleeding therapy with a request for more data

August 22, 2018 Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma

Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …

Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer

August 21, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma

AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …

FDA approves Bristol Myers Squibb’s Opdivo in small-cell lung cancer

August 20, 2018 Sales and Marketing Bristol-Myers Squibb, FDA, approval, bristol myers squibb, lung cancer, opdivo

The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first …

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018 Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …

Thyroid medication recalled after Chinese supplier fails inspection

August 20, 2018 Sales and Marketing China, FDA, recall, thyroid, westminster

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …

More children suffering from type 2 diabetes in England and Wales

August 20, 2018 Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …

Chinese regulators approve Roche’s Alecensa in regulatory shift

August 20, 2018 Sales and Marketing Cancer, China, Roche, approval, lung cancer

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …

Gilead CMO announces departure alongside two new exec appointments

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018 Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …

NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay

August 14, 2018 Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy

UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
The Gateway to Local Adoption Series

Latest content